Which companies overlap with Grupo de Investigación Clínica en Oncología Radioterapia's portfolio?

Top competitors by shared drug class: AstraZeneca, Beijing InnoCare Pharma Tech Co., Ltd., Betta Pharmaceuticals Co., Ltd., Genentech, Inc., Hangzhou ACEA Pharmaceutical Research Co., Ltd..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/grupo-de-investigaci-n-cl-nica-en-oncolog-a-radioterapia.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Grupo de Investigación Clínica en Oncología Radioterapia — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Grupo de Investigación Clínica en Oncología Radioterapia pipeline: 0 marketed, 0 filed, 1 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 1 Phase 3 0 Phase 2 1 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Erlotinib chlorhydrate	Erlotinib chlorhydrate	phase 3	EGFR tyrosine kinase inhibitor	EGFR (epidermal growth factor receptor)	Oncology

Therapeutic area mix

Oncology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

AstraZeneca · 1 shared drug class
Beijing InnoCare Pharma Tech Co., Ltd. · 1 shared drug class
Betta Pharmaceuticals Co., Ltd. · 1 shared drug class
Genentech, Inc. · 1 shared drug class
Hangzhou ACEA Pharmaceutical Research Co., Ltd. · 1 shared drug class
Hoffmann-La Roche · 1 shared drug class
Millennium Pharmaceuticals, Inc. · 1 shared drug class
Pfizer · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Grupo de Investigación Clínica en Oncología Radioterapia:

Cite this brief

Drug Landscape (2026). Grupo de Investigación Clínica en Oncología Radioterapia — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/grupo-de-investigaci-n-cl-nica-en-oncolog-a-radioterapia. Accessed 2026-05-17.